Working with Singapore researchers, IBM has engineered a chemical that blocks viruses like Zika, Ebola, dengue, influenza, herpes, and more.
Read more
Category: biotech/medical – Page 2753
Chinese technology giant Huawei is preparing for a world where people live forever, dead relatives linger on in computers and robots try to kill humans.
Huawei is best known as one of the world’s largest producers of broadband network equipment and smartphones. But Kevin Ho, president of its handset product line, told the CES Asia conference in Shanghai on Wednesday the company used science fiction movies like “The Matrix” to envision future trends and new business ideas.
“Hunger, poverty, disease or even death may not be a problem by 2035, or 25 years from now,” he said. “In the future you may be able to purchase computing capacity to serve as a surrogate, to pass the baton from the physical world to the digital world.”
Read more
University of Oxford scientists have developed a gene therapy that has shown promise in treating choroideremia, a rare disorder that causes progressive vision loss, mostly in males.
Doctors tested the treatment method on six patients with choroideremia by injecting numerous healthy genes into the eye to replace missing ones in the retina. The purpose of this therapy is to hinder or prevent loss of sight, according to Oxford’s announcement.
Results varied for each participant. Two patients experienced a big improvement in vision that lasted for four years, but a decline occurred in the other untreated eye. Three separate patients maintained their vision in the treated eye over four years whereas the sixth recipient who was given a lower dose succumbed to vision decline in both eyes.
Read more
A nanoparticle commonly used in food, cosmetics, sunscreen and other products can have subtle effects on the activity of genes expressing enzymes that address oxidative stress inside two types of cells. While the titanium dioxide (TiO2) nanoparticles are considered non-toxic because they don’t kill cells at low concentrations, these cellular effects could add to concerns about long-term exposure to the nanomaterial.
Researchers at the Georgia Institute of Technology used high-throughput screening techniques to study the effects of titanium dioxide nanoparticles on the expression of 84 genes related to cellular oxidative stress. Their work found that six genes, four of them from a single gene family, were affected by a 24-hour exposure to the nanoparticles.
The effect was seen in two different kinds of cells exposed to the nanoparticles: human HeLa cancer cells commonly used in research, and a line of monkey kidney cells. Polystyrene nanoparticles similar in size and surface electrical charge to the titanium dioxide nanoparticles did not produce a similar effect on gene expression.
Read more
Lifeboat is all about how advances in science & technology can be use to improve humanity and ensure folks are informed. I also see this story as an opportunity for others to learn to improve humanity through sharing & hearing from a man who has been successful, met amazing people, and seen amazing things & places; and now shares his most important lesson of life.
Tom Brokaw spoke about his battle with incurable blood cancer in an emotional interview on Today Monday morning and how it has made him appreciate life more and brought him closer to some new friends.
Brokaw, 76, said he had met some incredible people also suffering from cancer, including a younger family friend who passed away last year.
Next time you go for a brain scan; you could actually see dissolvable electrodes.
Hmmm
Scientists at the University of Pennsylvania in a study funded by the Defense Advance Research Projects Agency (DARPA) are developing implantable electrodes for brain monitoring that melt away at a predetermined rate. The devices could come in handy for monitoring and treating certain neurophysiological disorders such as Parkinson’s, depression and chronic pain.
The electrodes, which are made from layers of silicon and a chemical element, molybdenum, dissolve at a known rate according to thickness. The devices can provide “continuous streams of data for guiding medical care over predetermined periods of time,” Brian Litt, senior co-author on the study and a professor of neurology, neurosurgery and bioengineering at UPenn, said in a statement.
Hmmm; I see a bright future for this. No more surgeries by plastic surgeons? possibly?
Scientists at MIT, Massachusetts General Hospital, Living Proof, and Olivo Labs have developed a new material that can temporarily protect and tighten skin, and smooth wrinkles. With further development, it could also be used to deliver drugs to help treat skin conditions such as eczema and other types of dermatitis.
The material, a silicone-based polymer that could be applied on the skin as a thin, imperceptible coating, mimics the mechanical and elastic properties of healthy, youthful skin. In tests with human subjects, the researchers found that the material was able to reshape “eye bags” under the lower eyelids and also enhance skin hydration. This type of “second skin” could also be adapted to provide long-lasting ultraviolet protection, the researchers say.
“It’s an invisible layer that can provide a barrier, provide cosmetic improvement, and potentially deliver a drug locally to the area that’s being treated. Those three things together could really make it ideal for use in humans,” says Daniel Anderson, an associate professor in MIT’s Department of Chemical Engineering and a member of MIT’s Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science (IMES).